Evidence map›Paper›PMID 39277836›Full record

ArticleJournal of nephrology2024

Association between serum potassium, risk and prognosis of peritonitis in peritoneal dialysis patients - results from the Peritoneal Dialysis Telemedicine-assisted Platform Cohort (PDTAP) Study.

Zi Wang, Xiaoying Ma, Shaomei Li, Huaying Pei, Jinghong Zhao, Ying Zhang, Zibo Xiong, Yumei Liao, Ying Li, Qiongzhen Lin and 45 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of nephrology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

55 authors.

Zi Wang *Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
Xiaoying Ma *Renal Division, Department of Medicine, Cangzhou Central Hospital, Cangzhou, Hebei, China.
Shaomei LiRenal Division, Department of Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Huaying PeiRenal Division, Department of Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Jinghong ZhaoDepartment of Nephrology, The Key Laboratory for the Prevention and Treatment of Chronic Kidney Disease of Chongqing, Chongqing Clinical Research Center of Kidney and Urology Diseases, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
Ying ZhangDepartment of Nephrology, The Key Laboratory for the Prevention and Treatment of Chronic Kidney Disease of Chongqing, Chongqing Clinical Research Center of Kidney and Urology Diseases, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
Zibo XiongRenal Division, Department of Medicine, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China.
Yumei LiaoRenal Division, Department of Medicine, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China.
Ying LiRenal Division, Department of Medicine, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Qiongzhen LinRenal Division, Department of Medicine, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Wenbo HuRenal Division, Department of Medicine, People's Hospital of Qinghai Province, Xining, Qinghai, China.
Yulin LiRenal Division, Department of Medicine, People's Hospital of Qinghai Province, Xining, Qinghai, China.
Zhaoxia ZhengRenal Division, Department of Medicine, Handan Central Hospital, Handan, Hebei, China.
Liping DuanRenal Division, Department of Medicine, Handan Central Hospital, Handan, Hebei, China.
Gang FuRenal Division, Department of Medicine, Peking Haidian Hospital, Beijing, China.
Shanshan GuoRenal Division, Department of Medicine, Peking Haidian Hospital, Beijing, China.
Beiru ZhangDepartment of Nephrology, Shengjing Hospital of China Medical University, Shenyang , Liaoning, China.
Rui YuDepartment of Nephrology, Shengjing Hospital of China Medical University, Shenyang , Liaoning, China.
Li HaoRenal Division, Department of Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Guiling LiuRenal Division, Department of Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Zhanzheng ZhaoRenal Division, Department of Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Jing XiaoRenal Division, Department of Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Yulan ShenRenal Division, Department of Medicine, Beijing Miyun District Hospital, Beijing, China.
Yong ZhangRenal Division, Department of Medicine, Beijing Miyun District Hospital, Beijing, China.
Xuanyi DuRenal Division, Department of Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Tianrong JiRenal Division, Department of Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Caili WangRenal Division, Department of Medicine, The First Affiliated Hospital of BaoTou Medical College, Baotou, Neimenggu, China.
Lirong DengRenal Division, Department of Medicine, The First Affiliated Hospital of BaoTou Medical College, Baotou, Neimenggu, China.
Yingli YueRenal Division, Department of Medicine, People's Hospital of Langfang, Langfang, Hebei, China.
Shanshan ChenRenal Division, Department of Medicine, People's Hospital of Langfang, Langfang, Hebei, China.
Zhigang MaRenal Division, Department of Medicine, People's Hospital of Gansu, Lanzhou, Gansu, China.
Yingping LiRenal Division, Department of Medicine, People's Hospital of Gansu, Lanzhou, Gansu, China.
Li ZuoRenal Division, Department of Medicine, Peking University People's Hospital, Beijing, China.
Huiping ZhaoRenal Division, Department of Medicine, Peking University People's Hospital, Beijing, China.
Xianchao ZhangRenal Division, Department of Medicine, Pingdingshan First People's Hospital, Pingdingshan, Henan, China.
Xuejian WangRenal Division, Department of Medicine, Pingdingshan First People's Hospital, Pingdingshan, Henan, China.
Yirong LiuRenal Division, Department of Medicine, The First People's Hospital of Xining, Xining, Qinghai, China.
Xinying GaoRenal Division, Department of Medicine, The First People's Hospital of Xining, Xining, Qinghai, China.
Xiaoli ChenRenal Division, Department of Medicine, Taiyuan Central Hospital, Taiyuan, Shanxi, China.
Hongyi LiRenal Division, Department of Medicine, Taiyuan Central Hospital, Taiyuan, Shanxi, China.
Shutong DuRenal Division, Department of Medicine, Cangzhou People's Hospital, Cangzhou, Hebei, China.
Cui ZhaoRenal Division, Department of Medicine, Cangzhou People's Hospital, Cangzhou, Hebei, China.
Zhonggao XuRenal Division, Department of Medicine, First Hospital of Jilin University, Changchun, Jilin, China.
Li ZhangRenal Division, Department of Medicine, First Hospital of Jilin University, Changchun, Jilin, China.
Hongyu ChenRenal Division, Department of Medicine, The People's Hospital of Chuxiong Yi Autonomous Prefecture, Chuxiong, Yunnan, China.
Li LiRenal Division, Department of Medicine, The People's Hospital of Chuxiong Yi Autonomous Prefecture, Chuxiong, Yunnan, China.
Lihua WangRenal Division, Department of Medicine, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Yan YanRenal Division, Department of Medicine, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Yingchun MaRenal Division, Department of Medicine, China Rehabilitation Research Center, Beijing Boai Hospital, Beijing, China.
Yuanyuan WeiRenal Division, Department of Medicine, China Rehabilitation Research Center, Beijing Boai Hospital, Beijing, China.
Jingwei ZhouRenal Division, Department of Medicine, Beijing Dongzhimen Hospital, Beijing, China.
Yan LiRenal Division, Department of Medicine, Beijing Dongzhimen Hospital, Beijing, China.
Fuyun SunRenal Division, Department of Medicine, Cangzhou Central Hospital, Cangzhou, Hebei, China. 13315777305@163.com.
Jie DongRenal Division, Department of Medicine, Peking University First Hospital, Beijing, China. jie.dong@bjmu.edu.cn.ORCID 0000-0001-7298-3307
PDTAP working group

Funding

CAMS Innovation Fund for Medical Sciences (2019-I2M-5-046)Capital Health Research and Development of Special Fund (2020-2-4079)
6 · The paper itself

Abstract

backgroundHypokalemia has been associated with an increased risk of peritoneal dialysis (PD)-associated peritonitis. However, hypokalemia is commonly associated with malnutrition, inflammation, and severe coexisting comorbidities, which thus are suspected of being potential confounders. This study was aimed at testing whether hypokalemia was independently associated with the occurrence and prognosis of PD-associated peritonitis.

methodsA national-level dataset from the Peritoneal Dialysis Telemedicine-assisted Platform Cohort (PDTAP) Study was used to explore the independent association of serum potassium with PD-associated peritonitis. Unmatched and propensity score-adjusted multivariate competing risk models, as well as univariate competing risk models following 1:1 propensity score matching, were conducted to balance potential biases between patients with and without hypokalemia. The association between potassium levels prior to peritonitis and treatment failure due to peritonitis was also investigated.

resultsDuring a median follow-up of 25.7 months in 7220 PD patients, there was a higher incidence of peritonitis in patients with serum potassium below 4.0 mmol/L compared to those with higher serum levels (677 [0.114/patient-year] vs. 914 [0.096/patient-year], P = 0.001). After adjusting for demographics, laboratory tests, residual renal function, and medication use, baseline potassium levels below 4.0 mmol/L were not linked to an increased risk of peritonitis, with a hazard ratio of 0.983 (95% CI 0.855-1.130, P = 0.810). This result remained consistent in both the propensity score adjusted multivariate competing risk regression (HR = 0.974, 95% CI 0.829-1.145, P = 0.750) and the univariate competing risk regression after 1:1 propensity score matching (Fine-Gray test, P = 0.218). The results were similar when analyzing patients with serum potassium level above or below 3.5 mmol/L. Lastly, hypokalemia before the occurrence of peritonitis was not independently associated with treatment failure.

conclusionHypokalemia was not found to be an independent risk factor for PD-associated peritonitis or treatment failure of peritonitis in China.

Indexed as

HypokalemiaPeritoneal DialysisPeritonitisPotassiumAdultAgedBiomarkersChinaFemaleHumansIncidenceMaleMiddle AgedPrognosisPropensity ScoreRisk AssessmentBiomarkersPotassiumHypokalemiaPDTAPPeritoneal dialysisPeritonitisTreatment failure

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.